People living with migraine recently gained another significant tool to effectively manage their condition when the U.S. Food and Drug Administration approved the first treatment to target calcitonin-gene-related peptides (CGRP). However, only one-third of respondents of Migraine In America 2018, a national survey by Health Union, LLC of people impacted by the condition, are even aware of CGRP therapies.
Living with lung cancer is accompanied by a considerable level of anxiety, with 86 percent of respondents reporting at least a little bit of anxiety on any given day. However, what is often referred to as “scanxiety” – the anxiety, fear and worry associated with scans, specifically before the results are revealed – can exacerbate those feelings. Of those who experience scanxiety, three-quarters reported either “more” or “a lot more” anxiety around the time of scans than at other times.
Health Union, LLC has been accepted for a poster presentation at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto. The poster, titled “Differentiating Characteristics of Patients Seeking a Second Opinion: A Survey on Non-Small Cell Lung Cancer Patients,” will be presented on Sept. 25.
Health Union, LLC has been accepted for an oral presentation at the 2018 Annual Meeting & Expo of the American Public Health Association (APHA) in San Diego. The presentation, based on the abstract titled “Perceived treatment satisfaction and effectiveness facilitators among patients with chronic health conditions: A self-reported survey,” will occur at 3 p.m. on Nov. 12.
Despite the physical, emotional and social challenges faced, three-fifths of people living with blood cancer feel that their condition is under control with current treatment plans, according to Blood Cancer In America 2018, a national survey by Health Union, LLC of people diagnosed with the condition and caregivers.
PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech and medical device sectors, has named Olivier Chateau, CEO & co-founder of Health Union, LLC as one of the 2018 PM360 ELITE 100 in the Entrepreneurs category.
People living with skin cancer struggle with perceptions that their condition is less serious than other types of cancer despite significant physical and emotional impact, according to Skin Cancer In America 2018, a national survey by Health Union, LLC of people diagnosed with the condition.
The emotional impact of prostate cancer – from diagnosis to side effects from treatments – often outweighs the physical impact, according to “Prostate Cancer In America,” a national survey by Health Union, LLC of men with prostate cancer and their caregivers.
Health Union was named the No. 1 business in the Small Employer category in the 2018 Philadelphia Top Workplaces program. Additionally, Health Union CEO and co-founder Olivier Chateau received a recognition award that honors employees’ confidence in his leadership.
Pharmaceutical industry veteran Adam Kesselman has joined Health Union, LLC in the newly created role of senior vice president of corporate development. With more than 20 years of industry experience, Kesselman will continue to build on the company’s growth and strengthen relationships with various partners.
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
Privacy Policy
Terms of Use
Your Privacy Choices 
Join Our Team
Press Kit